Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis: What does the literature say?
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely recommended and prescribed to treat pain in osteoarthritis. While measured to have a moderate effect on pain in osteoarthritis, NSAIDs have been associated with wide-ranging adverse events affecting the gastrointestinal, cardiovascular, and r...
主要な著者: | Cooper, C, Chapurlat, R, Al-Daghri, N, Herrero-Beaumont, G, Bruyère, O, Rannou, F, Roth, R, Uebelhart, D, Reginster, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Springer International Publishing
2019
|
類似資料
-
Recommendations for the reporting of harms in manuscripts on clinical trials assessing osteoarthritis drugs: A consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
著者:: Honvo, G, 等
出版事項: (2019) -
Strontium Ranelate Significantly Decreases Radiological Progression Using a New Definition For Radiological Progression In Patients With Primary Knee Osteoarthritis Treated With Strontium Ranelate
著者:: Bruyere, O, 等
出版事項: (2013) -
Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: consensus of a working group of the ESCEO
著者:: Reginster, J, 等
出版事項: (2018) -
Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis.
著者:: Bruyère, O, 等
出版事項: (2014) -
Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines
著者:: Arden, NK, 等
出版事項: (2020)